{
    "address": "Kungsbroplan 3",
    "city": "Stockholm",
    "country": "SE",
    "currency": "SEK",
    "cusip": "",
    "description": "BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm and currently employs 160 full-time employees.  The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company\u2019s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee\u2019s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.",
    "employeeTotal": "160.0",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Biotechnology",
    "ggroup": "Pharmaceuticals, Biotechnology & Life Sciences",
    "gind": "Biotechnology",
    "gsector": "Health Care",
    "gsubind": "Biotechnology",
    "ipo": "1998-01-01",
    "isin": "SE0000470395",
    "logo": "https://finnhub.io/api/logo?symbol=BIOG B.ST",
    "marketCapitalization": 9591.706,
    "naics": "Other Food Manufacturing",
    "naicsNationalIndustry": "All Other Miscellaneous Food Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Food Manufacturing",
    "name": "Biogaia AB",
    "phone": "46855529300.0",
    "sedol": "5473124",
    "shareOutstanding": 20.196462,
    "state": "STOCKHOLM",
    "ticker": "BIOG B.ST",
    "weburl": "https://www.biogaia.se/"
}